Status:
UNKNOWN
Effect of ERCC and/or PEEP-ZEEP Maneuver on Oxygenation, Ventilation, and Airway Secretions Removal in MV Patients
Lead Sponsor:
Damanhour University
Conditions:
Mechanically Ventilated Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Mechanical ventilation (MV) is crucial in managing respiratory insufficiency. However, prolonged use can cause complications. Various strategies have been explored to optimize patient outcomes. Patie...
Detailed Description
Expiratory rib cage compression is a form of chest physiotherapy that involves squeezing the chest with the hands during expiration and releasing it at the end of expiration to aid in the mobilization...
Eligibility Criteria
Inclusion
- Patients who are aged ≥18 years.
- Patients who have tracheal intubation and are likely to require MV for ≥72 hours.
- Patients who are hemodynamically stable: Heart rate (HR): ≥ 60 b or ≤100 b/min, mean arterial pressure (MAP) ≥ 90 mmHg, central venous pressure ≥ 3 or ≤ 8 cmH2O.
Exclusion
- Patients with pneumothorax, rib fracture, and subcutaneous emphysema.
- Patients with traumatic brain injuries and spinal cord injuries.
- Patients with ARDS who require high PEEP levels (\>10 cmH2O).
- Patients admitted with pneumonia.
- Pregnant patients.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06182553
Start Date
January 1 2024
End Date
August 1 2024
Last Update
December 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.